Equus Total Return, Inc. operates as a business development company structured like a closed-end fund on the New York Stock Exchange under the symbol EQS. It focuses on debt and equity investments in smaller businesses with enterprise values typically between $5 million and $75 million, including growth financings, buyouts, and special situations.
In practice, the portfolio remains highly concentrated rather than broadly diversified. The two main holdings are Morgan E&P, a majority-owned private oil and gas firm with development rights to about 6,500 net acres in North Dakota’s Williston Basin, and a stake in publicly traded CitroTech, which develops fire-suppression products. Investors track the name for its exposure to these assets, the reported net asset value, and the discount to that NAV.
Over the past 30 days, EQS moved from a closing price near $0.84 in mid-October to around $0.56 in mid-November, representing a decline of about 33%. The path was uneven, with prices holding in the $0.85–$0.95 range early in the period before breaking lower toward the end of October and slipping below $0.60 in early November.
The three-month view shows a steeper drop. Shares closed near $1.12 in mid-August, and the move down to roughly $0.56 equates to a loss of about 50%. The stock remains well below the $1.00 level that previously prompted a formal NYSE non-compliance notice.
The most recent weakness stems from a mix of structural issues and limited liquidity rather than any single event. Average daily volume often runs in just a few thousand shares, so even modest order flow can drive large percentage moves in a name that trades under $1.00.
Investor sentiment continues to reflect longer-standing concerns: a portfolio heavily weighted toward one illiquid private energy asset and one public fire-suppression holding, five straight years of net investment losses, no dividend since 2009, and a going-concern paragraph in the fiscal 2025 auditor’s report. Ongoing uncertainty around NYSE listing compliance adds another layer of pressure.
The roughly 50% decline over three months fits into a longer-term downtrend. In June 2026, activist investor Howard Todd Horberg disclosed a Schedule 13D stake of about 5.61% and published an open letter urging greater board accountability and a strategic review, pointing to years of net losses, elevated operating costs relative to size, and a NAV per share that had fallen from prior levels.
These governance and valuation questions have layered onto the company’s structural challenges. Equus finished 2025 with roughly $133,000 in cash, while its largest holding, Morgan E&P, was valued largely on management estimates and produced minimal revenue. Because much of the portfolio’s value ties to crude oil prices through Morgan E&P, energy market moves can affect reported NAV and investor expectations.
Investors following EQS will want to monitor upcoming quarterly NAV updates, which serve as the main valuation reference. The next disclosure should clarify how Morgan E&P and the CitroTech position have fared amid energy prices and market conditions. Oil price trends remain particularly relevant given Morgan E&P’s weighting.
Additional items to track include any response to the activist’s call for a strategic review, steps toward resolving the NYSE listing issue, the company’s cash position, and management’s handling of the going-concern note from the fiscal 2025 audit. Given the micro-cap closed-end structure and low trading volume, liquidity and execution risks warrant attention in any position sizing.
When evaluating names with limited liquidity and concentrated holdings like this one, I sometimes cross-check signals with Tickeron’s AI Daily Buy/Sell Signals to see how automated models are interpreting recent price action and volume patterns. It provides an additional data point alongside traditional NAV and fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Stochastic Oscillator for EQS moved into oversold territory on November 11, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EQS's RSI Indicator exited the oversold zone, 20 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where EQS advanced for three days, in 107 of 162 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
EQS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EQS as a result. In 113 of 137 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for EQS turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 58 similar instances when the indicator turned negative. In 52 of the 58 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
EQS moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for EQS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.538) is normal, around the industry mean (2.412). P/E Ratio (-0.478) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (1.319). Dividend Yield (0.988) settles around the average of (0.270) among similar stocks. P/S Ratio (1.130) is also within normal values, averaging (15.694).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. EQS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EQS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers